Whitehawk Therapeutics Inc
(WHWK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,984 | -13,466 | -8,580 | -4,195 | -31 |
| Depreciation Amortization | 258 | 172 | 97 | 17 | N/A |
| Accounts receivable | 114 | 109 | 114 | 64 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 1 |
| Other Working Capital | 516 | 1 | 303 | 180 | 10 |
| Other Operating Activity | 377 | 507 | 221 | 62 | -1 |
| Operating Cash Flow | $-15,718 | $-12,676 | $-7,845 | $-3,873 | $-22 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -113 | -113 | -110 | N/A |
| Investing Cash Flow | $-113 | $-113 | $-113 | $-110 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,542 | 9,073 | 4,537 | N/A | N/A |
| Common Stock Issued | 19 | 19 | 19 | N/A | N/A |
| Other Financing Activity | -264 | -138 | -138 | 0 | 35 |
| Financing Cash Flow | $12,297 | $8,954 | $4,417 | $N/A | $35 |
| Beginning Cash Position | 5,144 | 5,144 | 5,144 | 5,144 | 5 |
| End Cash Position | 1,610 | 1,308 | 1,603 | 1,161 | 19 |
| Net Cash Flow | $-3,535 | $-3,836 | $-3,542 | $-3,984 | $13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,718 | -12,676 | -7,845 | -3,873 | -22 |
| Capital Expenditure | -113 | -113 | -113 | -110 | N/A |
| Free Cash Flow | -15,831 | -12,790 | -7,959 | -3,984 | -22 |